scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41436-018-0024-6 |
P698 | PubMed publication ID | 29760485 |
P50 | author | Amy Taylor | Q88671188 |
P2093 | author name string | Brendan H Lee | |
Heidi V Russell | |||
Seema R Lalani | |||
Jose-Miguel Yamal | |||
Marcia C de Oliveira Otto | |||
J Michael Swint | |||
Hadley Stevens Smith | |||
Stephan Castellanos | |||
P2860 | cites work | Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases | Q21144939 |
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
Genetic diagnosis by whole exome capture and massively parallel DNA sequencing | Q22066282 | ||
Clinical application of exome sequencing in undiagnosed genetic conditions | Q24604127 | ||
Targeted capture and massively parallel sequencing of 12 human exomes | Q24615381 | ||
Hyperekplexia, microcephaly and simplified gyral pattern caused by novel ASNS mutations, case report | Q27311640 | ||
Compound heterozygous variants in PGAP1 causing severe psychomotor retardation, brain atrophy, recurrent apneas and delayed myelination: a case report and literature review | Q28074745 | ||
A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease | Q28238461 | ||
Hoyeraal-Hreidarsson syndrome with a DKC1 mutation identified by whole-exome sequencing | Q28241714 | ||
A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes | Q28261627 | ||
AMMECR1: a single point mutation causes developmental delay, midface hypoplasia and elliptocytosis | Q28975784 | ||
Identification of a novel SBF2 frameshift mutation in charcot-marie-tooth disease type 4B2 using whole-exome sequencing | Q30412617 | ||
De novo FGF12 mutation in 2 patients with neonatal-onset epilepsy | Q30828995 | ||
A case of splenomegaly in CBL syndrome | Q33441037 | ||
Syndrome of progressive bone marrow failure and pancreatic insufficiency remains cryptic despite whole exome sequencing: variant of Shwachman-Diamond syndrome or new condition? | Q33442475 | ||
Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy: A case report with RAF1 770C>T mutant | Q33595276 | ||
Clinical exome sequencing identifies a novel TUBB4A mutation in a child with static hypomyelinating leukodystrophy | Q33645665 | ||
Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine | Q33736038 | ||
Genomic diagnosis for children with intellectual disability and/or developmental delay | Q33737759 | ||
Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration. | Q33755919 | ||
Compound heterozygous mutations in glycyl-tRNA synthetase (GARS) cause mitochondrial respiratory chain dysfunction | Q33778406 | ||
De novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea | Q33794553 | ||
Whole-exome sequencing identifies a de novo TUBA1A mutation in a patient with sporadic malformations of cortical development: a case report | Q33988618 | ||
TUBB4A de novo mutations cause isolated hypomyelination | Q34129815 | ||
Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia | Q34212011 | ||
Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus | Q34219041 | ||
Clinical whole-exome sequencing for the diagnosis of mendelian disorders | Q34413680 | ||
Use of next-generation sequencing as a diagnostic tool for congenital myasthenic syndrome. | Q34437194 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration | Q34503708 | ||
Clinical exome sequencing for genetic identification of rare Mendelian disorders | Q34782655 | ||
Genetic test evaluation: information needs of clinicians, policy makers, and the public | Q34786260 | ||
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders | Q34866575 | ||
Identification of a novel de novo p.Phe932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy | Q35001819 | ||
Molecular findings among patients referred for clinical whole-exome sequencing | Q35078373 | ||
Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation | Q35155236 | ||
De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay | Q35221908 | ||
Molecular diagnosis of long QT syndrome at 10 days of life by rapid whole genome sequencing | Q35232613 | ||
Whole exome sequencing of suspected mitochondrial patients in clinical practice. | Q35607615 | ||
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings | Q35776062 | ||
Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities | Q35834127 | ||
Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center's Experience. | Q35910407 | ||
Congenital hyperinsulinism and glycogenosis-like phenotype due to a novel HNF4A mutation | Q36292438 | ||
Economic analyses of human genetics services: a systematic review | Q36296074 | ||
Diagnosis of D-Bifunctional Protein Deficiency through Whole-Genome Sequencing: Implications for Cost-Effective Care | Q36423179 | ||
The use of whole-exome sequencing to disentangle complex phenotypes | Q36474993 | ||
A Case of HDR Syndrome and Ichthyosis: Dual Diagnosis by Whole-Genome Sequencing of Novel Mutations in GATA3 and STS Genes | Q36715998 | ||
Successful diagnosis of HIBCH deficiency from exome sequencing and positive retrospective analysis of newborn screening cards in two siblings presenting with Leigh's disease | Q36856769 | ||
Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies. | Q36924136 | ||
A patient with a novel homozygous missense mutation in FTO and concomitant nonsense mutation in CETP. | Q36936123 | ||
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? | Q37029751 | ||
Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit | Q37162309 | ||
Exome Sequencing and the Management of Neurometabolic Disorders. | Q37171865 | ||
Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing | Q37211277 | ||
A de novo frameshift in HNRNPK causing a Kabuki-like syndrome with nodular heterotopia. | Q37221985 | ||
Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care | Q37316405 | ||
Implementing genomic medicine in the clinic: the future is here | Q37328458 | ||
Deficiency of the alkaline ceramidase ACER3 manifests in early childhood by progressive leukodystrophy | Q37347941 | ||
DNM1L-related mitochondrial fission defect presenting as refractory epilepsy | Q37351458 | ||
Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing | Q37411360 | ||
Thiamine pyrophosphokinase deficiency causes a Leigh Disease like phenotype in a sibling pair: identification through whole exome sequencing and management strategies | Q37434098 | ||
Issues surrounding the health economic evaluation of genomic technologies | Q37541151 | ||
An atypical presentation of ACAD9 deficiency: Diagnosis by whole exome sequencing broadens the phenotypic spectrum and alters treatment approach | Q37569260 | ||
Microcephaly-capillary malformation syndrome: Brothers with a homozygous STAMBP mutation, uncovered by exome sequencing. | Q52124333 | ||
An Infant With Epilepsy and Recurrent Hemiplegia due to Compound Heterozygous Variants in ATP1A2. | Q52543121 | ||
Monoallelic FGFR3 and Biallelic ALPL mutations in a Thai girl with hypochondroplasia and hypophosphatasia. | Q52553543 | ||
Multigenerational pedigree with STAR syndrome: A novel FAM58A variant and expansion of the phenotype. | Q52888556 | ||
Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant. | Q53414773 | ||
Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy. | Q53475467 | ||
Clinical and molecular characterization of de novo loss of function variants in HNRNPU. | Q53553368 | ||
Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability. | Q53716635 | ||
Further Validation of the SIGMAR1 c.151+1G>T Mutation as Cause of Distal Hereditary Motor Neuropathy. | Q53753835 | ||
HIBCH deficiency in a patient with phenotypic characteristics of mitochondrial disorders. | Q54682256 | ||
An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B. | Q55521682 | ||
WDR35 mutation in siblings with Sensenbrenner syndrome: a ciliopathy with variable phenotype. | Q55692902 | ||
A further family of Stromme syndrome carrying CENPF mutation | Q57096776 | ||
Molecular diagnosis of infantile onset inflammatory bowel disease by exome sequencing | Q57186049 | ||
Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results | Q62056090 | ||
GM3 synthase deficiency due to ST3GAL5 variants in two Korean female siblings: Masquerading as Rett syndrome-like phenotype | Q64048253 | ||
Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value | Q64049894 | ||
Utility of next-generation sequencing technologies for the efficient genetic resolution of haematological disorders | Q86796883 | ||
Right test, right time, right patient | Q86965148 | ||
CLTC as a clinically novel gene associated with multiple malformations and developmental delay | Q87179685 | ||
Novel myopathy in a newborn with Shwachman-Diamond syndrome and review of neonatal presentation | Q87270985 | ||
Dual molecular diagnosis contributes to atypical Prader-Willi phenotype in monozygotic twins | Q88347856 | ||
Neonatal-Onset Recurrent Guillain-Barré Syndrome-Like Disease: Clues for Inherited CD59 Deficiency | Q88757356 | ||
Exome sequencing is a valuable approach in critically ill patients with suspected monogenic disease: Diagnosis of X-linked centronuclear myopathy in preterm twins | Q89006694 | ||
Novel HPS6 mutations identified by whole-exome sequencing in two Japanese sisters with suspected ocular albinism | Q89287901 | ||
Distinct but milder phenotypes with choreiform movements in siblings with compound heterozygous mutations in the transcription preinitiation mediator complex subunit 17 (MED17). | Q40907558 | ||
Alpha-thalassemia X-linked intellectual disability syndrome identified by whole exome sequencing in two boys with white matter changes and developmental retardation | Q40982455 | ||
Rapid whole-genome sequencing identifies a novel homozygous NPC1 variant associated with Niemann-Pick type C1 disease in a 7-week-old male with cholestasis. | Q41369880 | ||
Practical considerations in the clinical application of whole-exome sequencing | Q41441536 | ||
Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. | Q41641120 | ||
Novel Causative Variants in DYRK1A, KARS, and KAT6A Associated with Intellectual Disability and Additional Phenotypic Features | Q41919782 | ||
The first report of Japanese patients with asparagine synthetase deficiency. | Q41922159 | ||
Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation | Q41926755 | ||
Novel compound heterozygous DNA ligase IV mutations in an adolescent with a slowly-progressing radiosensitive-severe combined immunodeficiency | Q41927776 | ||
High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders | Q41927928 | ||
Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research | Q41997840 | ||
A Novel Intragenic SLC16A1 Mutation Associated With Congenital Hyperinsulinism | Q42114467 | ||
Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy | Q42166178 | ||
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray | Q42204762 | ||
Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report | Q42376293 | ||
H syndrome: 5 new cases from the United States with novel features and responses to therapy | Q42682569 | ||
Bilateral cataracts in a 6-yr-old with new onset diabetes: a novel presentation of a known INS gene mutation | Q42838805 | ||
Severe combined immunodeficiency resulting from mutations in MTHFD1. | Q43593496 | ||
Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. | Q44413471 | ||
The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders | Q45225641 | ||
A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome. | Q45938326 | ||
Retinopathy and optic atrophy: Expanding the phenotypic spectrum of pathogenic variants in the AARS2 gene. | Q45963395 | ||
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy | Q46498407 | ||
An infant with MLH3 variants, FOXG1-duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study | Q46564552 | ||
Novel de novo SCN2A mutation in a child with migrating focal seizures of infancy | Q47674528 | ||
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. | Q47681796 | ||
Yunis-Varón syndrome caused by biallelic VAC14 mutations | Q47723480 | ||
Congenital myopathy due to myosin heavy chain 2 mutation presenting as chronic aspiration pneumonia in infancy. | Q47826524 | ||
Heterogeneity of FHF1 related phenotype: Novel case with early onset severe attacks of apnea, partial mitochondrial respiratory chain complex II deficiency, neonatal onset seizures without neurodegeneration. | Q47891009 | ||
Novel compound heterozygous mutations identified by whole exome sequencing in a Japanese patient with geroderma osteodysplastica | Q47953634 | ||
A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy | Q47980981 | ||
Huppke-Brendel syndrome in a seven months old boy with a novel 2-bp deletion in SLC33A1. | Q48001042 | ||
TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy. | Q48175460 | ||
Expanding the molecular diversity and phenotypic spectrum of glycerol 3-phosphate dehydrogenase 1 deficiency. | Q48178046 | ||
Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing | Q48200809 | ||
Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders. | Q48272320 | ||
Neonatal encephalocardiomyopathy caused by mutations in VARS2. | Q48582037 | ||
Ketogenic diet - A novel treatment for early epileptic encephalopathy due to PIGA deficiency. | Q48786663 | ||
Diagnostic challenge of Diamond-Blackfan anemia in mothers and children by whole-exome sequencing. | Q50222872 | ||
Prospective and Retrospective Diagnosis of Barth Syndrome Aided by Next-Generation Sequencing | Q50242626 | ||
Whole-exome sequencing reveals a novel COL2A1 mutation in a patient with spondylo-epiphyseal dysplasia congenita | Q50248419 | ||
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management. | Q50260153 | ||
Clinical whole exome sequencing in child neurology practice. | Q50305196 | ||
Hematopoietic stem cell transplantation corrects osteopetrosis in a child carrying a novel homozygous mutation in the FERMT3 gene. | Q50312970 | ||
A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly | Q50355103 | ||
Autosomal recessive truncating MAB21L1 mutation associated with a syndromic scrotal agenesis. | Q50518606 | ||
MORFAN Syndrome: An Infantile Hypoinsulinemic Hypoketotic Hypoglycemia Due to an AKT2 Mutation. | Q50584895 | ||
Application of whole exome sequencing to a rare inherited metabolic disease with neurological and gastrointestinal manifestations: a congenital disorder of glycosylation mimicking glycogen storage disease. | Q50601064 | ||
The usefulness of whole-exome sequencing in routine clinical practice. | Q50657606 | ||
Infantile epileptic encephalopathy with a hyperkinetic movement disorder and hand stereotypies associated with a novel SCN1A mutation. | Q50666945 | ||
Bilateral striatal necrosis caused by ADAR mutations in two siblings with dystonia and freckles-like skin changes that should be differentiated from Leigh syndrome. | Q50922188 | ||
Clinical, Electrodiagnostic, and Genetic Features of Tangier Disease in an Adolescent Girl with Presentation of Peripheral Neuropathy. | Q50970271 | ||
Congenital Sucrase-isomaltase Deficiency: A Novel Compound Heterozygous Mutation Causing Aberrant Protein Localization. | Q51384834 | ||
Before and after - Nutritional transformation of dysmorphism in a case of Costello syndrome. | Q51429599 | ||
Infantile Cirrhosis, Growth Impairment, and Neurodevelopmental Anomalies Associated with Deficiency of PPP1R15B. | Q51494602 | ||
Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. | Q51708433 | ||
Clinical exome sequencing: results from 2819 samples reflecting 1000 families. | Q37599237 | ||
The economic value of personalized medicine tests: what we know and what we need to know | Q37629385 | ||
Outcomes of interest in evidence-based evaluations of genetic tests | Q37684710 | ||
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. | Q38093984 | ||
Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing | Q38252010 | ||
Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. | Q38263926 | ||
Novel SMC1A frameshift mutations in children with developmental delay and epilepsy | Q38589512 | ||
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. | Q38644619 | ||
A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder | Q38687777 | ||
Mutations in SLC5A6 associated with brain, immune, bone, and intestinal dysfunction in a young child | Q38728153 | ||
Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis | Q38728522 | ||
Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience | Q38761141 | ||
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders | Q38802675 | ||
The use of whole exome sequencing for the diagnosis of autosomal recessive malignant infantile osteopetrosis | Q38836324 | ||
A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology | Q38883296 | ||
Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis | Q38895948 | ||
Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. | Q38912161 | ||
Do the exome: A case of Williams-Beuren syndrome with severe epilepsy due to a truncating de novo variant in GABRA1. | Q38950599 | ||
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. | Q38997779 | ||
Rayyan-a web and mobile app for systematic reviews. | Q39029662 | ||
Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. | Q39146974 | ||
Two cases of early-onset myoclonic seizures with continuous parietal delta activity caused by EEF1A2 mutations | Q39179079 | ||
Calpain 12 Function Revealed through the Study of an Atypical Case of Autosomal Recessive Congenital Ichthyosis | Q39260466 | ||
Recessive AFG3L2 Mutation Causes Progressive Microcephaly, Early Onset Seizures, Spasticity, and Basal Ganglia Involvement. | Q39267643 | ||
Impact of next generation sequencing on diagnostics in a genetic skin disease clinic | Q39307002 | ||
Precision Molecular Diagnosis Defines Specific Therapy in Combined Immunodeficiency with Megaloblastic Anemia Secondary to MTHFD1 Deficiency | Q39319437 | ||
ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. | Q39384466 | ||
Identification of two novel SH3PXD2B gene mutations in Frank-Ter Haar syndrome by exome sequencing: Case report and review of the literature | Q39426760 | ||
Novel mutations in the CYP11B2 gene causing aldosterone synthase deficiency | Q39952428 | ||
Whole Wiskott‑Aldrich syndrome protein gene deletion identified by high throughput sequencing | Q40049687 | ||
Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. | Q40117585 | ||
Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis--The phenotype of two patients with novel mutations in the PIGN and PGAP2 genes | Q40118159 | ||
Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases. | Q40159468 | ||
Mutated PET117 causes complex IV deficiency and is associated with neurodevelopmental regression and medulla oblongata lesions. | Q40261041 | ||
Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder | Q40588093 | ||
P433 | issue | 1 | |
P921 | main subject | scoping review | Q101116078 |
P304 | page(s) | 3-16 | |
P577 | publication date | 2018-05-14 | |
P1433 | published in | Genetics in Medicine | Q15765508 |
P1476 | title | Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature | |
P478 | volume | 21 |
Q98287670 | A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients |
Q64117643 | Data Science for Child Health |
Q99618750 | Evaluating systematic reanalysis of clinical genomic data in rare disease from single center experience and literature review |
Q93238062 | Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions |
Q89553180 | Genetic Tests by Next Generation Sequencing in Children with Developmental Delay and/or Intellectual disability |
Q91386086 | Personalised analytics for rare disease diagnostics |
Q91718745 | Primary care provider perspectives on using genomic sequencing in the care of healthy children |
Q90714631 | Rapid exome sequencing in PICU patients with new-onset metabolic or neurological disorders |
Q90590119 | Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability |
Q60683707 | The Genetic Landscape of Diamond-Blackfan Anemia |
Q92966078 | The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders |
Q91623230 | Using the Delphi method to identify clinicians' perceived importance of pediatric exome sequencing results |
Q64040030 | Whole genome sequencing reveals that genetic conditions are frequent in intensively ill children |
Search more.